- Home
- BBDO vs ILMN Comparison
BBDO vs ILMN Comparison
Compare BBDO & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBDO
- ILMN
- Stock Information
- Founded
- BBDO 1943
- ILMN 1998
- Country
- BBDO Brazil
- ILMN United States
- Employees
- BBDO N/A
- ILMN N/A
- Industry
- BBDO Major Banks
- ILMN Medical Specialities
- Sector
- BBDO Finance
- ILMN Health Care
- Exchange
- BBDO Nasdaq
- ILMN Nasdaq
- Market Cap
- BBDO 28.5B
- ILMN 16.0B
- IPO Year
- BBDO N/A
- ILMN 2000
- Fundamental
- Price
- BBDO $2.79
- ILMN $100.92
- Analyst Decision
- BBDO Strong Buy
- ILMN Buy
- Analyst Count
- BBDO 4
- ILMN 15
- Target Price
- BBDO $2.55
- ILMN $123.67
- AVG Volume (30 Days)
- BBDO 29.5K
- ILMN 1.3M
- Earning Date
- BBDO 10-30-2025
- ILMN 11-03-2025
- Dividend Yield
- BBDO 4.15%
- ILMN N/A
- EPS Growth
- BBDO 58.81
- ILMN N/A
- EPS
- BBDO 0.36
- ILMN 7.91
- Revenue
- BBDO $16,114,445,927.00
- ILMN $4,284,000,000.00
- Revenue This Year
- BBDO $72.65
- ILMN N/A
- Revenue Next Year
- BBDO $8.90
- ILMN $2.76
- P/E Ratio
- BBDO $8.13
- ILMN $12.64
- Revenue Growth
- BBDO 27.09
- ILMN N/A
- 52 Week Low
- BBDO $1.71
- ILMN $68.70
- 52 Week High
- BBDO $2.88
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- BBDO 63.77
- ILMN 54.31
- Support Level
- BBDO $2.69
- ILMN $95.12
- Resistance Level
- BBDO $2.80
- ILMN $99.56
- Average True Range (ATR)
- BBDO 0.07
- ILMN 3.05
- MACD
- BBDO 0.01
- ILMN -0.04
- Stochastic Oscillator
- BBDO 89.28
- ILMN 98.73
About BBDO Banco Bradesco Sa (each representing one Common Share)
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.